Published in Virol J on June 24, 2016
Hand, foot, and mouth disease in China, 2008-12: an epidemiological study. Lancet Infect Dis (2014) 6.80
Virology, epidemiology, pathogenesis, and control of enterovirus 71. Lancet Infect Dis (2010) 5.97
Effect of long term consumption of probiotic milk on infections in children attending day care centres: double blind, randomised trial. BMJ (2001) 2.91
Potential uses of probiotics in clinical practice. Clin Microbiol Rev (2003) 2.80
Molecular analysis of coxsackievirus A16 reveals a new genetic group of enteroviruses. Virology (1994) 2.13
Effect of long-term consumption of a probiotic bacterium, Lactobacillus rhamnosus GG, in milk on dental caries and caries risk in children. Caries Res (2002) 1.92
New scientific paradigms for probiotics and prebiotics. J Clin Gastroenterol (2003) 1.88
Outbreak of hand, foot and mouth disease/herpangina associated with coxsackievirus A6 and A10 infections in 2010, France: a large citywide, prospective observational study. Clin Microbiol Infect (2012) 1.79
Retrograde axonal transport: a major transmission route of enterovirus 71 in mice. J Virol (2007) 1.61
Removal of antibiotic resistance gene-carrying plasmids from Lactobacillus reuteri ATCC 55730 and characterization of the resulting daughter strain, L. reuteri DSM 17938. Appl Environ Microbiol (2008) 1.49
A non-mouse-adapted enterovirus 71 (EV71) strain exhibits neurotropism, causing neurological manifestations in a novel mouse model of EV71 infection. J Virol (2011) 1.44
Effects of probiotic bacteria on diarrhea, lipid metabolism, and carcinogenesis: a review of papers published between 1988 and 1998. Am J Clin Nutr (2000) 1.42
Probiotic beverage containing Lactobacillus casei Shirota improves gastrointestinal symptoms in patients with chronic constipation. Can J Gastroenterol (2003) 1.36
Complete sequence analyses of enterovirus 71 strains from fatal and non-fatal cases of the hand, foot and mouth disease outbreak in Singapore (2000). Microbiol Immunol (2002) 1.33
Coxsackievirus A16: epidemiology, diagnosis, and vaccine. Hum Vaccin Immunother (2013) 1.31
Probiotics as functional food in the treatment of diarrhea. Curr Opin Clin Nutr Metab Care (2006) 1.24
Randomized trial of dietary fiber and Lactobacillus casei administration for prevention of colorectal tumors. Int J Cancer (2005) 1.18
Inhibitory activity spectrum of reuterin produced by Lactobacillus reuteri against intestinal bacteria. BMC Microbiol (2007) 1.16
Epidemiological and clinical characteristics of children who died from hand, foot and mouth disease in Vietnam, 2011. BMC Infect Dis (2014) 1.12
Update of enterovirus 71 infection: epidemiology, pathogenesis and vaccine. Expert Rev Anti Infect Ther (2014) 1.11
Viral and host factors that contribute to pathogenicity of enterovirus 71. Future Microbiol (2012) 1.09
Purification and structural characterization of 3-hydroxypropionaldehyde and its derivatives. J Agric Food Chem (2003) 1.05
Pathogenicity of a poliomyelitis-like disease in monkeys infected orally with enterovirus 71: a model for human infection. Neuropathol Appl Neurobiol (1982) 1.02
Probiotic Lactobacilli for urogenital health in women. J Clin Gastroenterol (2008) 1.02
Formalin-inactivated EV71 vaccine candidate induced cross-neutralizing antibody against subgenotypes B1, B4, B5 and C4A in adult volunteers. PLoS One (2013) 1.01
Prospect and challenges for the development of multivalent vaccines against hand, foot and mouth diseases. Vaccine (2014) 0.98
Seroepidemiology of Coxsackievirus A6, Coxsackievirus A16, and Enterovirus 71 Infections among Children and Adolescents in Singapore, 2008-2010. PLoS One (2015) 0.94
The cytokine and chemokine profiles in patients with hand, foot and mouth disease of different severities in Shanghai, China, 2010. PLoS Negl Trop Dis (2013) 0.94
Clinical usefulness of probiotics in inflammatory bowel diseases. J Physiol Pharmacol (2006) 0.92
Probiotics in allergy management. J Pediatr Gastroenterol Nutr (2008) 0.92
Evaluation of monovalent and bivalent vaccines against lethal Enterovirus 71 and Coxsackievirus A16 infection in newborn mice. Hum Vaccin Immunother (2014) 0.88
Lactobacillus reuteri DSM 17938 effectively reduces the duration of acute diarrhoea in hospitalised children. Acta Paediatr (2014) 0.88
Development of enterovirus 71 vaccines: from the lab bench to Phase III clinical trials. Expert Rev Vaccines (2014) 0.87
Understanding Enterovirus 71 Neuropathogenesis and Its Impact on Other Neurotropic Enteroviruses. Brain Pathol (2015) 0.85
Clinical safety of Lactobacillus casei shirota as a probiotic in critically ill children. J Pediatr Gastroenterol Nutr (2006) 0.85
A case of neonatal coxsackie B2 meningo-encephalitis in which serial magnetic resonance imaging findings reveal the development of lesions. Neuropediatrics (2011) 0.84
Probiotics and gut health in infants: A preliminary case-control observational study about early treatment with Lactobacillus reuteri DSM 17938. Clin Chim Acta (2015) 0.84
The efficacy of Lactobacillus reuteri DSM 17938 in infants and children: a review of the current evidence. Eur J Pediatr (2014) 0.84
Antiviral potential of lactic Acid bacteria and their bacteriocins. Probiotics Antimicrob Proteins (2014) 0.81
Preventive effects of oral probiotic on infantile colic: a prospective, randomised, blinded, controlled trial using Lactobacillus reuteri DSM 17938. Benef Microbes (2015) 0.81
Daily intake of fermented milk with Lactobacillus casei strain Shirota reduces the incidence and duration of upper respiratory tract infections in healthy middle-aged office workers. Eur J Nutr (2015) 0.80
Antiviral activity of Lactobacillus brevis towards herpes simplex virus type 2: role of cell wall associated components. Anaerobe (2011) 0.80